MediPharm Labs Statistics

Total Valuation

MediPharm Labs has a market cap or net worth of CAD 37.36 million. The enterprise value is 25.88 million.

Market Cap	37.36M
Enterprise Value	25.88M

Important Dates

The next estimated earnings date is Thursday, May 15, 2025.

Earnings Date	May 15, 2025
Ex-Dividend Date	n/a

Share Statistics

MediPharm Labs has 415.14 million shares outstanding. The number of shares has increased by 12.30% in one year.

Current Share Class	n/a
Shares Outstanding	415.14M
Shares Change (YoY)	+12.30%
Shares Change (QoQ)	+0.18%
Owned by Insiders (%)	6.71%
Owned by Institutions (%)	0.00%
Float	387.28M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	0.89
PB Ratio	0.87
P/TBV Ratio	0.88
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-2.42
EV / Sales	0.62
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-5.16

Financial Position

The company has a current ratio of 3.15, with a Debt / Equity ratio of 0.01.

Current Ratio	3.15
Quick Ratio	1.85
Debt / Equity	0.01
Debt / EBITDA	n/a
Debt / FCF	-0.08
Interest Coverage	-15.21

Financial Efficiency

Return on equity (ROE) is -22.24% and return on invested capital (ROIC) is -11.08%.

Return on Equity (ROE)	-22.24%
Return on Assets (ROA)	-9.31%
Return on Invested Capital (ROIC)	-11.08%
Return on Capital Employed (ROCE)	-20.27%
Revenue Per Employee	260,627
Profits Per Employee	-66,422
Employee Count	161
Asset Turnover	0.71
Inventory Turnover	3.08

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +12.50% in the last 52 weeks. The beta is 0.56, so MediPharm Labs's price volatility has been lower than the market average.

Beta (5Y)	0.56
52-Week Price Change	+12.50%
50-Day Moving Average	0.08
200-Day Moving Average	0.07
Relative Strength Index (RSI)	53.25
Average Volume (20 Days)	195,580

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, MediPharm Labs had revenue of CAD 41.96 million and -10.69 million in losses. Loss per share was -0.03.

Revenue	41.96M
Gross Profit	13.54M
Operating Income	-8.76M
Pretax Income	-10.69M
Net Income	-10.69M
EBITDA	-6.23M
EBIT	-8.76M
Loss Per Share	-0.03

Full Income Statement

Balance Sheet

The company has 11.88 million in cash and 388,000 in debt, giving a net cash position of 11.49 million or 0.03 per share.

Cash & Cash Equivalents	11.88M
Total Debt	388,000
Net Cash	11.49M
Net Cash Per Share	0.03
Equity (Book Value)	43.18M
Book Value Per Share	0.10
Working Capital	22.59M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -4.86 million and capital expenditures -154,000, giving a free cash flow of -5.02 million.

Operating Cash Flow	-4.86M
Capital Expenditures	-154,000
Free Cash Flow	-5.02M
FCF Per Share	-0.01

Full Cash Flow Statement

Margins

Gross margin is 32.26%, with operating and profit margins of -20.88% and -25.49%.

Gross Margin	32.26%
Operating Margin	-20.88%
Pretax Margin	-25.49%
Profit Margin	-25.49%
EBITDA Margin	-14.84%
EBIT Margin	-20.88%
FCF Margin	n/a

Dividends & Yields

MediPharm Labs does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-12.30%
Shareholder Yield	-12.30%
Earnings Yield	-28.62%
FCF Yield	-13.42%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

MediPharm Labs has an Altman Z-Score of -2.48. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-2.48
Piotroski F-Score	n/a